Smiths Detection enters healthcare field with diagnostic system
This article was originally published in Clinica
Smiths Medical’s detection and screening unit has taken its first steps to break into the healthcare market by developing a rapid diagnostic system for infectious diseases. Smiths Detection, said to be a global leader in developing threat detection and screening technologies for military, transportation, homeland security and resilience applications, believes the clinical diagnostic version of its Bio-Seeq system will provide easy-to-use lab or point-of-care tests for diseases such as MRSA and Clostridium difficile. London, UK-based firm Smiths said that the test would not require manual sample preparation and a variety of solid and liquid samples can be used. The firm expects trials of clinical diagnostic system to begin in early 2009 and is currently seeking partners to co-develop a range of tests to run on the system. The underlying technology for Bio-Seeq is also being applied in animal health.